Insulin Cost Cap Splits Democrats Seeking Broad Drug-Price Curbs

Senate Democrats are testing whether a cap on what many Americans pay for insulin medication can muster bipartisan support, even as advocates for reining in drug prices differ over strategy.

Some vocal advocates for Democrats’ sweeping changes to drug pricing say they’re worried action on one measure could mean leaving the rest of the agenda behind. Broad measures were included in the Build Back Better domestic spending package (H.R. 5376) that’s stalled in the Senate.

Senate Majority Leader Chuck Schumer (D-N.Y.) recently announced that a bill to cap what people with insurance pay for insulin from Sen. Raphael ...